Results
|
|
1.
|
|
|
|
2.
|
Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. MedStar authors:
- Epstein, Stephen E
- Lipinski, Michael J
Year: 2017
Citation: - Circulation Research. 120(2):332-340, 2017 Jan 20
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Anderson AS, Butler J, Cole RT, Epstein SE, Gheorghiade M, Greene SJ, Kim RJ, Ko YA, Lipinski MJ, Margulies KB, Quyyumi AA, Sikora S, Skopicki HA, Tankovich NI, Wilcox JE
|
|
|
3.
|
Intravenously-Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy. MedStar authors:
- Epstein, Stephen E
- Lipinski, Michael J
- Luger, Dror
- Waksman, Ron
- Westman, Peter C
Year: 2017
Citation: - Circulation Research. 120(10):1598-1613, 2017 May 12
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Albelda MT, Dimastromatteo J, Epstein SE, Frias JC, Glover DK, Kharazi A, Lipinski MJ, Luger D, Sikora S, Vertelov G, Waksman R, Westman PC
|
